Sep 17
FRX · Fennec Pharmaceuticals Inc. · Documents
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's reports, filings, earnings calls and investor events, most recent first. Search these from Claude or ChatGPT →
2026
Sep 17
Announcement
SEDAR+
News release
Sep 15
Sep 15
Aug 13
Quarterly report
10-Q
FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2
AI summary on its way
Revenue $17.87M
▲ 85.2%
Net income $1.97M
Diluted EPS $0.05
Aug 13
Report
SEDAR+
MD&A
Aug 13
Report
SEDAR+
Interim financial statements/report
Aug 13
Filing
SEDAR+
52-109F2 - Certification of interim filings - CEO (E)
Aug 13
Filing
SEDAR+
52-109F2 - Certification of interim filings - CFO (E)
Aug 11
Aug 11
Announcement
SEDAR+
News release
Jun 30
Jun 15
Announcement
SEDAR+
News release
Jun 10
May 22
May 21
Announcement
SEDAR+
News release
May 19
Investor event
H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
AI summary on its way
May 19
Investor event
H.C. WAINWRIGHT 4TH ANNUAL BIOCONNECT INVESTOR CONFERENCE AT NASDAQ
AI summary on its way
May 18
May 14
May 14
Quarterly report
10-Q
FY2026 Q1, ended Mar 31
Quarterly report for FY2026 Q1
AI summary on its way
Revenue $15.11M
▲ 72.6%
Net income $201K
Diluted EPS $0.01
May 14
Report
SEDAR+
Interim financial statements/report
May 14
Filing
SEDAR+
52-109F2 - Certification of interim filings - CFO (E)
May 14
Announcement
SEDAR+
News release
May 14
Report
SEDAR+
MD&A
May 14
Filing
SEDAR+
52-109F2 - Certification of interim filings - CEO (E)
May 7
Announcement
SEDAR+
News release
Apr 28
Apr 28
Current report
8-K
Events of Apr 27
Director or officer change, or executive pay
AI summary on its way
Apr 28
Meeting document
SEDAR+
Form of proxy
Apr 28
Meeting document
SEDAR+
Notice of meeting
Apr 28
Meeting document
SEDAR+
Management information circular
Apr 22
Apr 21
Announcement
SEDAR+
News release
Apr 14
Meeting document
SEDAR+
Notice of the meeting and record date
Apr 7
Apr 7
Announcement
SEDAR+
News release
Mar 27
Annual report
10-K
Ended Dec 31
Annual report for the period ended Dec 31, 2025
AI summary on its way
Revenue $44.64M
▼ 6.1%
Net loss $9.74M
Diluted EPS -$0.34
Mar 27
Filing
SEDAR+
52-109F1 - Certification of annual filings - CFO (E)
Mar 27
Filing
SEDAR+
Participation fee form
Mar 27
Filing
SEDAR+
Participation fee form
Mar 27
Filing
SEDAR+
52-109F1 - Certification of annual filings - CEO (E)
Mar 27
Report
SEDAR+
Annual report on Form 10-K
Mar 27
Report
SEDAR+
MD&A
Mar 27
Announcement
SEDAR+
News release
Mar 27
Report
SEDAR+
Auditors' consent letter
Mar 27
Report
SEDAR+
Audited annual financial statements
Mar 24
Mar 24
Mar 24
Announcement
SEDAR+
News release
Showing 1–50 of 527 documents